The Physician Payments Report includes payments and related expenses paid directly and indirectly to U.S. physicians, or on the behalf of a U.S. physician, for a physician's participation on a speaker bureau, research, or for providing other consulting services. It also includes business meals provided to U.S. physicians as well as any research funding or educational grants they may receive directly. Reports will be posted online quarterly. This report is now published in accordance with the J&J Pharmaceutical Affiliates Corporate Integrity Agreement with the Office of the Inspector General of the U.S. Department of Justice.
Payments related to product development will be reported four years after the date of payment or after the product receives U.S. Food and Drug Administration approval, whichever occurs earlier. This report will be updated as products in development payments become reportable.
The report includes information about payments made during the calendar years 2010, 2011, 2012, and 2013 relating to the OMJPI Corporate integrity agreement and one quarter (October 1st through December 31st) for the remaining Pharmaceutical affiliates relating to the J&J Pharmaceutical affiliated CIA. The report includes payments that were available at the time of report preparation. Any payment information received after this time will be included in subsequent reports.
The information included in this report is the result of our best efforts to disclose information on payments and items of value provided to physicians. This information may differ from data available on third-party websites and, due to differences in requirements; the information included in these reports may differ from disclosures to state governments as required by law.